Immugenia
Sherbrooke
About Immugenia
Immugenia is an early-stage immuno-oncology company developing a novel approach to CAR therapy by engineering hematopoietic stem cells to treat cancer and prevent relapses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2022)
- Website: immugenia.com
Industries & Categories
Biotechnology, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immugenia-2425337 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.